Filing Details
- Accession Number:
- 0001140361-13-016375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-12 16:58:32
- Reporting Period:
- 2013-04-10
- Filing Date:
- 2013-04-12
- Accepted Time:
- 2013-04-12 16:58:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1274826 | Robert Baffi | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-04-10 | 20,000 | $14.39 | 72,350 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-10 | 20,000 | $64.00 | 52,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2013-04-10 | 20,000 | $0.00 | 20,000 | $14.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,051 | 2009-11-12 | 2019-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,238 | Indirect | Shares held by Baffi Family Trust |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on March 4, 2013.
- All shares sold at the same price.
- Options vest 6/48ths on November 12, 2009 and 1/48th on the 12th of each month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
